Control Material for Evaluating the Quality of Quantitative Determination of IgG Antibodies to RBD Domain of S-protein SARS-CoV-2 in Clinical Samples by Immunochemiluminescent Method on CL Series Analyzers

Control Material for Evaluating the Quality of Quantitative Determination of IgG Antibodies to RBD Domain of S-protein SARS-CoV-2 in Clinical Samples by Immunochemiluminescent Method on CL Series Analyzers

Variants available:

1. Control material for evaluating the quality of quantitative determination of IgG antibodies to RBD domain of S-protein SARS-CoV-2 in clinical samples by immunochemiluminescent method on CL series analyzers, 3 x 0.5 ml/vial, includes:
   • High-Level Control Material (SARS-CoV-2 S-RBD IgG Antibody Control (H)), 0.5 ml - 3 vials
   • Series values table of control materials
   • Instruction for use
2. Control material for evaluating the quality of quantitative determination of IgG antibodies to RBD domain of S-protein SARS-CoV-2 in clinical samples by immunochemiluminescent method on CL series analyzers, 6 x 0.5 ml/vial, includes:
   • High-Level Control Material (SARS-CoV-2 S-RBD IgG Antibody Control (H)), 0.5 ml - 6 vials
   • Series values table of control materials
   • Instruction for use
3. Control material for evaluating the quality of quantitative determination of IgG antibodies to RBD domain of S-protein SARS-CoV-2 in clinical samples by immunochemiluminescent method on CL series analyzers, 3 x 0.5 ml/vial, includes:
   • Low-Level Control Material (SARS-CoV-2 S-RBD IgG Antibody Control (L)), 0.5 ml - 3 vials
   • Series values table of control materials
   • Instruction for use
4. Control material for evaluating the quality of quantitative determination of IgG antibodies to RBD domain of S-protein SARS-CoV-2 in clinical samples by immunochemiluminescent method on CL series analyzers, 6 x 0.5 ml/vial, includes:
   • Low-Level Control Material (SARS-CoV-2 S-RBD IgG Antibody Control (L)), 0.5 ml - 6 vials
   • Series values table of control materials
   • Instruction for use

To purchase the Control Material for Evaluating the Quality of Quantitative Determination of IgG Antibodies to RBD Domain of S-protein SARS-CoV-2 in Clinical Samples by Immunochemiluminescent Method on CL Series Analyzers, please fill out a request form on our website or use the order form available at Адрес электронной почты защищен от спам-ботов. Для просмотра адреса в вашем браузере должен быть включен Javascript..